Visit the News Hub Targeted therapy shrank tumors, shows promise in improving survival Huy Mach The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial.

A federal appeals court upheld the FDA's approval of the key ingredient in Impossible Foods' fake meat products, GMO soy leghemoglobin. The decision allows Impossible Burgers to hit grocery stores and schools and ensures the potentially hazardous ingredient can remain on the market.